{"abstract": "An independent committee of directors of Alcon is disappointed with a takeover bid from Novartis, saying the Swiss drug maker is trying to circumvent protections for minority shareholders.", "web_url": "https://dealbook.nytimes.com/2010/01/05/alcon-directors-criticize-novartis-tactics/", "snippet": "An independent committee of directors of Alcon is disappointed with a takeover bid from Novartis, saying the Swiss drug maker is trying to circumvent protections for minority shareholders.", "lead_paragraph": "An independent committee of directors of Alcon is disappointed with a takeover bid from Novartis, saying Novartis, the Swiss drug maker, is trying to circumvent protections for minority shareholders.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Alcon Directors Criticize Novartis Tactics", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Alcon Incorporated", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 4, "major": "N"}, {"name": "glocations", "value": "Switzerland", "rank": 5, "major": "N"}], "pub_date": "2010-01-05T10:52:18+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/43a4966c-ca10-5890-8df5-74322804b5c9", "word_count": 334, "uri": "nyt://article/43a4966c-ca10-5890-8df5-74322804b5c9"}